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Abstract
Yersinia enterocolitica (Ye) evades the immune system of the host by injection of Yersinia outer proteins (Yops) via a type
three secretion system into host cells. In this study, a reporter system comprising a YopE-b-lactamase hybrid protein and a
fluorescent staining sensitive to b-lactamase cleavage was used to track Yop injection in cell culture and in an experimental
Ye mouse infection model. Experiments with GD25, GD25-b1A, and HeLa cells demonstrated that b1-integrins and
RhoGTPases play a role for Yop injection. As demonstrated by infection of splenocyte suspensions in vitro, injection of Yops
appears to occur randomly into all types of leukocytes. In contrast, upon infection of mice, Yop injection was detected in
13% of F4/80
+, 11% of CD11c
+, 7% of CD49b
+, 5% of Gr1
+ cells, 2.3% of CD19
+, and 2.6% of CD3
+ cells. Taking the different
abundance of these cell types in the spleen into account, the highest total number of Yop-injected cells represents B cells,
particularly CD19
+CD21
+CD23
+ follicular B cells, followed by neutrophils, dendritic cells, and macrophages, suggesting a
distinct cellular tropism of Ye. Yop-injected B cells displayed a significantly increased expression of CD69 compared to non-
Yop-injected B cells, indicating activation of these cells by Ye. Infection of IFN-cR (receptor)- and TNFRp55-deficient mice
resulted in increased numbers of Yop-injected spleen cells for yet unknown reasons. The YopE-b-lactamase hybrid protein
reporter system provides new insights into the modulation of host cell and immune responses by Ye Yops.
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Introduction
Yersinia enterocolitica (Ye) is an enteropathogenic bacterium that
causes gastrointestinal disorders such as enteritis and enterocolitis
as well as extraintestinal manifestations such as lymphadenitis,
reactive arthritis, and septicemia [1,2]. Ye has been demonstrated
to multiply extracellularly in host tissue. To accomplish this, Ye
needs to evade the host’s immune defense. Beside other virulence
factors, Ye evolved a type III secretion system (TTSS) consisting of
an injectisome and effector proteins the latter of which are injected
into host cells [3]. The injection of effectors into host cells via a
TTSS injectisome is a common strategy of pathogenic bacteria to
counteract the host’s immune response [4]. The TTSS injectisome
is complex ATP-driven protein-export machinery. Built of ring
shaped proteins, the basal body is providing a channel through the
bacterial membranes and the periplasm or the peptidoglycan wall,
respectively. The injectisome is terminating in a needle-like
structure that is protruding from the bacterial surface [5,6]. Thus,
pore-forming proteins enable the injection of the effector proteins
through the membrane of host target cells [7,8].
The TTSS is crucial for Yersinia virulence [9]. Ye injects at least
six effector Yops into host cells. YopP/J is a potent inhibitor of the
NF-kB and the MAPK signaling pathways and thus inhibits
downstream effects of these pathways such as proinflammatory
responses or antigen uptake [10–16]. In addition YopP induces
apoptosis in macrophages and dendritic cells [17–20]. YopE,
YopT and YopO affect RhoGTPase functions which leads to actin
cytoskeleton disruption and together with YopH, a tyrosine
phosphatase which targets different eukaryotic kinases, promote
inhibition of phagocytosis [21]. In addition, phosphatase activity of
YopH counteracts T cell activation [22,23]. YopM is known to
interact directly with protein kinase C-like 2 (PRK2) and
ribosomal S6 protein kinase 1 (RSK1), the function of YopM is
so far elusive [24].
Despite well defined and profound in vitro effects of Yops, the
contribution of some Yops to establish successful infection in a
mouse infection model seems to be rather insignificant (YopP/O/
T), while others (YopE/H/M) are of great importance for
virulence of Ye [9]. This highlights the necessity to understand
Yersinia pathogenicity in the context of whole organism infection. It
also creates the need for a tool to display the sites of interaction
between host organism and pathogen.
Various approaches have been taken to enable monitoring of
type three secretion into eukaryotic cells by Yersinia and other
pathogens during infection in cell culture. TTSS effectors have
been detected in host cells by immunocytochemistry and western
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cyclase (CyA) [27], Elk-tag [28] or Cre-recombinase [29]. Thus,
yersiniae expressing YopE-GFP could be used to detect fluorescent
bacteria in cell culture and mouse infection, but clear Yop
injection into host cells could not be shown or quantified [30]. The
YopE-CyA fusion was useful to detect Yop injection directly in
vitro and was utilized to demonstrate the requirement of YopB
and YopD for Yop injection by quantification of cAMP levels in
infected cells [27]. Briones et al. used a SopE-Cre reporter system
which allowed the visualization of Salmonella Sop injection at least
in a low number of cultured cells [29]. All these systems have
enabled interesting discoveries, but failed to detect Yop injection
on a single cell level and are not suitable for the quantitative
detection of targeted cells in mouse infection models.
Recently, a new reporter system for monitoring type III
secretion of bacterial proteins into host cells has been described
to study effector injection of enteric Escherichia coli [31] and
Salmonella enterica [32] as well as Yersinia pestis [30]. The reporter
systems consisted of translational fusions of a whole or truncated
TTSS effector protein with mature E. coli TEM-1 b-lactamase.
Infected cells were stained in these studies with the lipophilic
CCF2-AM [33], an esterified form of the CCF2 substrate. After
entry into the cells endogenous cytoplasmic esterases rapidly
convert CCF2-AM into its negatively charged form CCF2, which
is retained in the cytosol. CCF2 is a fluorescence resonance energy
transfer (FRET) substrate, which consists of a cephalosporin core
linking 7-hydroxycoumarin to fluorescein. Excitation of the
coumarin moiety at 409 nm results in a FRET to the fluorescein
residue leading to emission of light with a wavelength of 520 nm
(green fluorescence). Cleavage of the CCF2 substrate by TEM-1
b-lactamase separates the two fluorescent moieties and interrupts
the FRET between them. Excitation of the coumarin residue now
leads to the emission of light at a wavelength of 447 nm (blue
fluorescence). Marketon et al. [30] used an expression vector
which expressed YopM-b-lactamase fusion protein in Y. pestis for
infection experiments of mice. Using this system it was shown that
Yops were predominantly injected into granulocytes, dendritic
cells and macrophages while injection into T and B cells was found
to be a rare event. Geddes et al. [32] used translational fusions of
bla and effectors of the SPI-1/2 pathogenicity islands as reporters
and demonstrated that Salmonella targets preferentially granulo-
cytes in the spleen after mouse infection.
To investigate into which immune cells Yops are injected during
Y. enterocolitica infection in vivo, a Bla reporter system was
established to track Yop injection in infection in cell culture and
in an experimental mouse infection model. The established system
was validated as a powerful tool to investigate Yop injection in cell
culture as well as in a mouse infection model.
Results
Construction of a reporter system for tracking Y.
enterocolitica Yop injection into host cells
To establish a reporter system to detect Yop injection by Ye, the
expression vector pMK-Bla was transformed into E40 Dasd,
resulting in the strain E40-pBla, secreting a YopE53-b-lactamase
fusion protein (see Materials and Methods as well as Table 1). As a
control, a strain also harboring pMK-Bla but deficient in Yop
secretion (DYscN-pBla) was employed. As a further control the
plasmid pMK-Ova, which encodes for a translational fusion of
YopE53 with the ovalbumin aa 247–355 fragment, was trans-
formed into E40 Dasd resulting in E40-pOva. Expression and
secretion of YopE and the fusion proteins YopE53-Bla and
YopE53-Ova by the strains E40-pBla, E40-pOva and DYscN-pBla
was analyzed by immunoblotting. The data depicted in Figure 1A
indicate that YopE wild type and hybrid proteins were expressed
and secreted into the supernatant except by the DYscN-pBla
mutant which is deficient for Yop secretion. To confirm injection
of YopE and YopE53-Bla, HeLa cells were mock-infected or
infected with E40-pBla or DYscN-pBla and injection assays were
performed to detect YopE and YopE53-Bla by immunoblot using
anti-YopE antibodies. YopE injection was detectable after
infection with E40-pBla but not after infection with DYscN-pBla
(Figure 1B left panel). In contrast, a YopE-Bla band was hardly
visible. Only long overexposure led to a clearly visible YopE53-Bla
band in E40-pBla, but not DYscN-pBla infected cells (Figure 1B
right panel). This shows that YopE53-Bla is translocated into cells
but with a much lower efficacy than the wildtype YopE.
Detection of Yop injection into epithelial cells in vitro
To investigate the usability of the system to assay Yop injection
into host cells, HeLa cells were infected with the E40-pBla, E40-
pOva or DYscN-pBla mutant strains and subsequently stained
with CCF4-AM. In the presented study CCF4-AM was used
instead of CCF2-AM that was utilized in former studies, because
according to the manufacturer the FRET is slightly stronger with
this dye, resulting in less background staining. Microscopic analysis
of the uninfected cells as well as the controls including infection
with E40-pOva or DYscN-pBla showed only green net fluores-
cence resulting from intact FRET within CCF4 (Figure 1C). In
contrast, after E40-pBla infection, approximately half of the cells
showed a pronounced blue net fluorescence resulting from FRET
disruption by b-lactamase, suggesting that injection of the
YopE53-Bla hybrid protein occurred (Figure 1C).
To quantify cell numbers and fluorescence signal intensity, flow
cytometry was used. Green fluorescence resulting from CCF4-AM
dye substrate uptake, de-esterification and retention in infected
HeLa cells was equal to that observed in uninfected cells
(Figure 1D). It also reflects the viability of cells because dead cells
cannot retain the CCF4-dye (data not shown). After infection of
HeLa cells for 1 hour with E40-pBla (MOI 50), blue fluorescence
Author Summary
An important strategy of Yersinia enterocolitica (Ye) to
suppress the immune defense is to inject bacterial proteins
(Yersinia outer proteins, Yops) after cell contact directly
into host cells, which affects their functions. However,
tracking of cells in which Yop injection occurred has only
been described for Yersinia pestis thus far. We adapted the
described reporter system specifically for the use of
infections with Ye and report the usefulness and
limitations of this system. Using cell culture experiments,
we demonstrated that b1-integrins and the RhoGTPases
RhoA and Rac1 are involved in Yop injection. Since cell
culture experiments also revealed that Yop injection is
detectable in a similar manner into all subpopulations of
the spleen, the system can be used to detect interaction of
bacteria with host cells in vivo. In a mouse infection model
we found that follicular B cells, granulocytes, macrophag-
es, and dendritic cells are the main targets of Yop injection.
Interestingly, Yop-injected B cells displayed an increased
activation as indicated by increased CD69 expression. In
contrast, interaction of bacteria with T cells seems to be
rather a rare event. In immunocompromised gene-
targeted mice we found increased frequencies of Yop-
injected host cells for yet unknown reasons. Taken
together, this novel reporter system represents a powerful
tool to further study interaction of host cells with Ye.
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of the viable cells. In contrast, infection of HeLa cells with E40-
pOva or DYscN-pBla resulted in 0.4860.3% or 2.562.4% blue
cells, indicating that spontaneous cleavage of the substrate CCF4
after infection does not significantly occur and that Yop secretion
is essential to detect Yop injection into host cells.
Role of b1-integrins for Yop injection
Adhesion of Ye to host cells is mediated by interaction of host
cell b1-integrins with Yersinia invasin protein or YadA (indirectly
via collagen); moreover, adhesion of Ye to host cells is a
prerequisite for Yop injection into host cells [34]. To investigate
whether b1-integrins are essential for Yop injection, infection
experiments were performed with the fibroblast cell line GD25,
lacking b1-integrins and the cell line GD25-b1A, overexpressing
b1-integrins as indicated in Figure 2A. Infection of GD25 cells
with E40-pBla or E40-pOva (MOI 50) for one hour resulted in
0.960.2% or 0.1260.06% blue cells while infection of GD25-b1A
cells yielded 18.266% or 0.2260.12% blue cells, respectively
(Figure 2B). The strong reduction (95%) of Yop injection into
GD25 cells compared to GD25-b1A cells was also confirmed by
detection of YopE by immunoblots after infection with E40-pBla
(Figure 2C). To address whether reduced Yop injection into GD25
cells was due to reduced adhesion of Ye to GD25 compared to
GD25-b1A cells, cell adhesion assays were performed. GD25
showed a modest (40%) but significant decrease of the number of
adhering yersiniae compared to GD25-b1A cells (Figure 2D).
C. difficile toxin B (TcdB), an inhibitor of RhoA, was shown to
inhibit Yop injection while the Rac inhibitor NSC23766 had no
impact on Yop injection [35]. According to these data we
hypothesized that RhoA might be crucial for Yop injection. To
confirm the previous data, HeLa cells were pretreated with TcdB
or NSC23766 and then infected with E40-pBla and stained with
CCF4-AM (Figure 2E). Flow cytometry analysis revealed that the
number of blue cells was significantly decreased by TcdB, but not
by the Rac1 inhibitor NSC23766. Additionally, HeLa cells were
transfected with control siRNA (siCo) or siRNAs specific for the
RhoGTPases RhoA, Cdc42 or Rac1. The cells were subsequently
infected with E40-pBla, stained with CCF4-AM and analyzed by
flow cytometry (Figure 2E). Inhibition of RhoA and Rac1, but not
Cdc42, significantly reduced the number of blue cells by 25–30%
indicating that both Rac1 and RhoA play a role in Yop injection.
Detection of Yop injection into leukocytes in vitro
To investigate whether Yops are also injected into primary cells,
single cell suspensions were prepared from the spleen of C57BL/6
Table 1. Plasmids and bacterial strains used in this study.
Designation Genotype or Description Reference or Source
Plasmids
pBME53-YopT pACYC184 derivative containing HindIII-sycE-yopE53-BamHI-yopT-SalI. Cm
R [56]
pBME53-Cre Derivative of pBME53-YopT. BamHI-yopT – SalI fragment was replaced by BamHI –nls-cre–SalI
resulting in HindIII- sycE-yopE53-BamHI-nls-cre-SalI. Cm
R
This study
pIV2 Cloning vector based on a small kryptic plasmid from Y. enterocolitica biogroup 1A strain 29807
modified with a kanamycin resistance marker and a pBluescript MCS. Kan
R
[57]
pIV2-SycE-YopE53-Cre Derivative of pIV2 with insertion of HindIII sycE-yopE53-BamHI-nls-cre-SalI into MCS. Kan
R This study
pMK4 Derivative of pIV2-SycE-YopE53-Cre with insertion of asd under control of its own promoter
between the ApaIa n dXhoI sites. Kan
R
This study
pMK1 SalI-asd 39UTR-EcoRI-asd 59UTR-XbaI in pBluescript II SK(+). Amp
R This study
pMK2 SalI-asd 39UTR-EcoRI-asd 59UTR-XbaI in pMRS101. Cm
R This study
pMK3 asd mutator plasmid, derived from pMK2 by NotI digestion and relegation. Cm
R This study
pMRS101 Mutator plasmid. Cm
R [59]
pBME53-Bla Derivative of pBME53-YopT. BamHI-yopT – SalI fragment was replaced by BamHI–bla– SalI
resulting in HindIII sycE-yopE53-BamHI-bla-SalI. Cm
R
This study
pMK-Bla HindIII sycE-yopE53-BamHI-NLS-Cre-SalI fragment of pMK4 was replaced by a HindIII
sycE-yopE53-BamHI-bla-SalI fragment of pBM53-Bla. Kan
R
This study
pYopE1–138Ova247–355 pACYC184 derivative containing HindIII- sycE-yopE138-BamHI-ova147–355- SalI [58]
pBME53-Ova Derivative of pBME53-YopT. BamHI-yopT – SalI fragment was replaced by
BamHI– ova147–355- SalI. Cm
R
This study
pMK-Ova Derivative of pMK-Bla. BamHI-bla-SalI was replaced by BamHI– ova147–355- SalI from
pBME53-Ova. Kan
R
This study
pMSL41 pYV40 with deletion in the yscN gene (yscND169–177). Ars
R [27,59]
Y. enterocolitica E40 strains
E40 Serotype O:9 patient isolate. Nal
R,A r s
R [27]
E40 Dasd E40 strain with asd gene knockout, deficient in L-aspartate-dehydrogenase expression.
Nal
R,A r s
R, DAP
aux
This study
E40-pBla E40 Dasd strain transformed by pMK-Bla. Nal
R,A r s
R,K a n
R This study
pYV
2 Dasd pBla E40 Dasd pMK-Bla strain without pYV40 virulence plasmid. Nal
R,K a n
R This study
DYscN-pBla pYV
2 Dasd pBla strain transformed by pMSL41. Nal
R,A r s
R, Kan
R This study
E40-pOva E40 Dasd strain transformed by pMK-Ova. Nal
R,A r s
R,K a n
R This study
doi:10.1371/journal.ppat.1000551.t001
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PLoS Pathogens | www.plospathogens.org 3 August 2009 | Volume 5 | Issue 8 | e1000551Figure 1. Establishment of a b-lactamase reporter system and detection of Yop injection in HeLa cells. (A) Secreted (left panel) and
intracellular (right panel) YopE, YopE53-Bla and YopE53-Ova hybrid proteins derived from supernatants or pellets, respectively, of bacterial cultures
were detected by immunoblot using anti-YopE antibodies. To determine Yop injection into HeLa cells, cells were infected for 1 h (MOI 100) and
injection of YopE hybrid proteins was detected (B) by immunoblot using anti-YopE and anti-actin antibodies. To visualize YopE53-Bla exposure time
was extended (right panel). (C) Yop injection was detected as blue fluorescence by staining of cells with green fluorescent TEM-1 b-lactamase
sensitive FRET substrate CCF4-AM and subsequent visualization by immunofluorescence microscopy. Blue and green fluorescence recordings were
overlaid to get composite pictures. Blue and green cells are indicated with white and grey arrowheads, respectively. Alternatively, fluorescence of
cells was detected by (D) flow cytometry. After flow cytometry data were analyzed and depicted as histograms. The upper panel shows uptake of
CCF4-AM (green) by cells. The horizontal bar indicates the gating used to determine the number of b-lactamase positive cells revealing Yop-injection
(blue) in the lower panel. Representative data of one of four experiments are shown. For note: percentages of blue or green fluorescent cells found in
the histograms as depicted in this or other figures represent the results of this single experiment and are therefore discrepant to the means
summarizing always several experiments as described in the results section.
doi:10.1371/journal.ppat.1000551.g001
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PLoS Pathogens | www.plospathogens.org 4 August 2009 | Volume 5 | Issue 8 | e1000551Figure 2. Role of b1-integrins for Yop injection. GD25 and GD25-b1A cells were infected with E40-pOva or E40-pBla for one hour and
subsequently stained with CCF4-AM and analyzed by flow cytometry. Living cells with high green fluorescence of CCF substrate were gated and are
depicted in (A) dot blots. Data show the expression of b1-integrins (CD29) and blue fluorescence intensity of the coumarin product of uninfected or
infected GD25 (upper panel) and GD25-b1A cells (lower panel) of one experiment. (B) Data show percentage of blue cells as the mean6SEM
summarizing four independent experiments. Asterisks indicate significant differences (One-way ANOVA with Bonferroni corrections, p,0.001). (C)
Injection of YopE into cells was detected by immunoblot using anti-YopE and anti-actin antibodies. (D) Adhesion assays were performed after
infection of indicated cells with E40-pBla or E40-pOva for one hour. Bacteria and cells were stained with fuchsine and adherent bacteria per cell were
counted. Data depict the mean and SD of two independent experiments. Hela cells were either (E) pretreated with TcdB (200 ng/ml) for 2 hours or
pretreated with NSC23766 (100 mM) for three hours or (F) transfected with indicated siRNAs for 48 hours. Cells were subsequently infected with E40-
pBla (MOI 50) for one hour and stained with CCF-AM and analyzed by flow cytometry. Data show percentage of blue cells as the mean6SEM of two
(E) or three (F) independent experiments. Asterisks indicate significant differences compared to control (Paired t-test with control, p,0.05).
doi:10.1371/journal.ppat.1000551.g002
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strains at a MOI of 50 for one hour in vitro. Similar to infection of
HeLa cells, flow cytometry analysis showed that CCF4 dye
retention (green fluorescence) after infection of splenocytes was not
significantly affected by infection with the strains used (data not
shown). After infection of spleen cells for one hour with E40-pBla
(MOI 50) in 61.4611.4% of cells a blue fluorescence signal was
detectable indicating that 61% of splenocytes had been injected
with Yops (Figure 3A). In contrast, blue fluorescence was observed
in less than 0.3% of splenocytes after infection with E40-pOva or
DYscN-pBla. The low background of blue cells after infection with
E40-pOva indicates that spontaneous cleavage of CCF4 detectable
after infection with yersiniae is negligible. The low background
staining after infection with DYscN-pBla indicates that secretion of
YopE-Bla is a prerequisite for the detection of blue cells (Figure 3A)
and that expression of YopE-Bla inside the bacteria and potential
internalization of bacteria do not lead to significant blue
fluorescence.
To determine the relationship between the number of bacteria
per targeted host cell and the occurrence of blue cells (FRET
disruption), spleen cell suspensions were infected with E40-pBla
(and E40-pOva as a control) at various MOI for one hour and
then subjected to flow cytometry analysis (Figure 3B and C). The
data show that the percentage of blue cells correlates with the
infection dose (MOI) in a fashion that a strong increase of the
number of blue cells is followed by a saturation state. A hyperbolic
regression curve can be calculated (goodness of fit of r
2=0.0977)
with the formula: % blue cells = 846MOI/(16.9 + MOI). Using
this regression curve it can be calculated that an MOI of 16.961.9
would result in 50% blue cells. This regression curve also predicts
that in cell culture even at high MOI Yop injection appears to be
limited for yet unknown reasons.
We also investigated whether there might be preferential Yop
injection into certain cell types. To define the populations of the
spleen injected with YopE53-Bla, splenocytes were infected with
E40-pBla and then flow cytometry analysis was used to detect
distinct cell surface markers on and b-lactamase activity in the
cells. The data depicted in Figure 4A shows the composition of
spleen cells and confirmed that B cells (5762% CD19
+) and T
cells (3067% CD3
+) are the most abundant spleen cell
subpopulations. As shown in Figure 4B, the percentage of blue
cells in each analyzed spleen cell population ranged between
5866% to 82610% but revealed no significant differences
(p.0.05) indicating that Yop injection occurs into all cells types
to a similar degree. Consistently, the composition of blue spleen
cells (Figure 4C) is closely related to the frequency of the
subpopulations.
Detection of Yop injection into spleen cells of Ye infected
mice in vivo
To investigate whether Yop injection can be detected in vivo,
desferrioxamine-conditioned C57BL/6 mice were intravenously
infected with E40-pBla or E40-pOva; one to three days later
splenocyte suspensions were prepared, stained with CCF4-AM
and subjected to flow cytometry analysis (Figure 5A and Figure
S1). As indicated in Figure 5A and Figure S1, after infection with
E40-pBla a distinct population of blue cells (3.161.1% of total
spleen cells) could be identified which was not present in the spleen
of uninfected or E40-pOva (0.260.2%) infected mice. To confirm
data obtained by flow cytometry, cell suspensions were subjected
to flow cytometry cell sorting and subsequently analyzed by
fluorescence microscopy (data not shown).
Analysis of b-lactamase activity after infection for different time
periods revealed a time-dependent increase of the percentage of
blue cells with a maximum between two and three days after
infection. The highest bacterial burden in the spleen was found
between 24 and 48 hours after infection (Figure 5B). Increased
infection dose led to a modest increase of the bacterial load in the
spleen two days after infection (Figure 5C). However, an infection
with more than 5610
3 E40-pBla did not further increase the
bacterial burden in the spleen. The number of blue cells increased
with the infection dose. In Figure 5D the bacterial load in the
spleen and the percentage of blue cells from various experiments is
given. The best fit to approximate the correlation of bacterial load
and percentage of blue cells was obtained using a sigmoid
regression curve (Figure 5D) (goodness of fit: r
2=0.64, degrees of
freedom = 79, and Sy.x = 0.50). Plotting the percentage of blue
cells versus the bacterial load in the spleen also revealed that for
the detection of blue cells over background (defined as % blue
cells62-fold standard deviation = 0.6% blue cells) the bacterial
load has to be more than log10 CFU 5.6 per spleen.
To investigate in which cells Yops were injected, C57BL/6 mice
were infected with 5610
5 E40-pBla or E40-pOva for two days and
subsequently cells were stained with CCF4-AM and fluorescence
labeled antibodies binding distinct surface markers. Infection of
mice with E40-pOva or E40-pBla for two days resulted in a
bacterial load of log10 CFU 7.460.2 or log10 CFU 7.360.2 per
spleen. Immunostaining and flow cytometry analysis of spleen cells
revealed that infection with E40-pBla led to a significant change in
the composition of cell populations compared to uninfected
(Figure 5E). Thus, the number of Gr-1
+ (granulocytes), CD11c
+
(dendritic cells) and CD49
+ (NK) cells increased significantly, while
the number of CD3
+ T cells decreased significantly. Moreover, we
found that 13.465.1% of all F4/80
+ (macrophages), 7.262.7% of
all CD49
+ (NK cells), 10.963.8% of all CD11c
+ (dendritic cells)
and 5.561.8% of all Gr-1
+ (granulocytes) cells displayed blue
fluorescence indicating that they had been injected with YopE53-
Bla (Figure 5F). In contrast, only 2.361.3% of all CD3
+ (T cells)
and 2.661.1% of all CD19
+ (B cells) cells displayed blue
fluorescence. These data suggest that Yop injection upon Ye
infection in this mouse infection model occurred predominantly
into cells of the myeloid lineage representing the innate immune
system. Analysis of the composition of total spleen cells with blue
fluorescence regarding the percentage of each subpopulation of
cells revealed that related to the total number of blue cells
43.8611.3% were CD19
+, 40.867.6% were Gr-1
+, 26.963.7%
were CD11c
+, 23.668% were F4/80
+, 15.465.3% were CD49b
+,
and 10.463 were CD3
+. These data indicate that injection of
Yops occurred into both myeloid and lymphoid cells, most
frequently into B cells and granulocytes (Figure 5G).
Increased activation of Yop-injected B cells
Splenic B cell subpopulations comprise CD19
+CD21
hiCD23
2
(marginal zone B cells, MZ), CD19
+CD21
+CD23
+ (follicular B
cells, FO), and CD19
+CD21
lo (newly formed B cells, NFB) B cells.
To address whether Yop injection occurs in all of these B cell
subpopulations, cultured splenocytes were infected in vitro with
E40-pBla (MOI 50) for 1 hour and Yop injection was determined
after staining using antibodies for B cell markers and CCF4 (Figure
S2). The data show ,84% of B cells were blue indicating injection
of Yops; moreover, the different B cell subpopulations contributed
to the total number of CD19
+ blue cells according to their different
frequencies of MZ (,10%), FO (,70%) and NFB (,20%), as
injection of Yops occurred with similar efficacy in all B cell
subtypes in vitro.
To analyze Yop injection into B cells in vivo, desferrioxamine-
conditioned C57BL/6 mice were infected with 5610
5 E40-pBla
and two days later B cells were analyzed (Figure 6A). After
Yop Injection by Yersinia enterocolitica
PLoS Pathogens | www.plospathogens.org 6 August 2009 | Volume 5 | Issue 8 | e1000551Figure 3. Detection of Yop injection in cultured splenocytes. Splenocytes were infected with (A) different Yersinia strains (MOI 50) or (B) with
different infection doses of E40-pBla for 1 h. Subsequently cells were stained with CCF4-AM (A–B) and flow cytometry analysis was performed. Data in
A, depicted as histograms, show the green fluorescence of the substrate CCF4 and the percentage of green cells (upper panel) is marked. Only these
cells were gated to determine the number of blue fluorescent cells indicating injection of effector Yops and the b-lactamase reporter (lower panel).
Data in B depict the percentage of blue fluorescent cells after infection with E40-pBla or E40-pOva using different MOI and these data are summarized
in (C) for infection with E40 as mean6SEM of four independent experiments. The dotted line represents a calculated hyperbolic regression curve
(goodness of fit: r
2=0.977).
doi:10.1371/journal.ppat.1000551.g003
Yop Injection by Yersinia enterocolitica
PLoS Pathogens | www.plospathogens.org 7 August 2009 | Volume 5 | Issue 8 | e1000551infection, the composition of splenic B cell subpopulations
changed. Thus, the percentage of CD21
+CD23
+ (FO) (43.864
in infected versus 66%62 in uninfected mice) and the percentage
of CD21
hiCD23
2 (MZ) (3.660.9 in infected versus 9.261.4 in
uninfected mice) significantly decreased whereas the percentage of
CD21
lo (NFB) (47.263.8 in infected versus 22.260.9 in uninfected
mice) significantly increased. Taking the changes in total cell
numbers in the spleen into account, the total number of NFB
significantly increased while the total number of FO and MZ
remained largely unchanged (data not shown). Analysis of blue
(Yop-injected) B cells (,2% of total B cells) revealed that
64.4%61.7 of CD19
+ blue B cells were CD21
+CD23
+ (FO) B
cells indicating that Yersinia targets predominantly follicular B cells
(Figure 6C). In blue FO B cells, a distinct CD21
hiCD23
hi B cell
subpopulation (Figure 6D) was detected suggesting that injection
of Yops into FO is associated with an increased expression of
CD21 and CD23.
To address whether injection of Yops may affect activation of B
cells, expression of CD69, an early activation marker of B cells, was
determined. In splenocytes infected in vitro with E40-pBla,
increased CD69 expression was found in B cells (mean fluorescence
intensity, MFI; 7.5 in uninfected versus 29.8 in infected cultures).
Moreover, in Yop-injected B cells (green
+ blue
+), expression of
CD69 was higher compared with B cells not injected with Yops
(green
+ blue
2) (Figure 7A) suggesting that in vitro, injection of Yops
into B cells is associated with rapid activation of these cells.
Upon infection of mice with E40-pBla, ,2% of B cells were
injected with Yops (blue staining) (Figure 7B). Expression of CD69
was increased in splenic B cells compared with uninfected mice
(MFI of 26.1 in infected versus 12.3 in uninfected mice).
Moreover, in Yop-injected B cells (green
+ blue
+), expression of
CD69 was dramatically higher (MFI 76.4) compared with B cells
not injected with Yops (green
+ blue
2) (MFI 22.3). In conclusion,
these data suggest that direct interaction of Ye with B cells
including injection of Yops leads to activation of B cells as
indicated by increased CD69 expression.
Investigation of Yop injection after infection of TNF-Rp55
and IFN-cR deficient mice
Previous studies showed that TNFRp55
2/2 and IFN-cR
2/2
mice are highly susceptible to infection with Ye [36–40] indicating
that the pleiotropic effects of IFN-c and TNF-a are crucial for the
defense against yersiniae. To investigate whether such gene defects
may modulate Yop injection, desferrioxamine conditioned
TNFRp55
2/2, IFN-cR
2/2, and wild type mice were infected
with Ye and two days later, splenocytes suspensions were
prepared, stained with antibodies and CCF4-AM, and subjected
to flow cytometry analysis. Infection of TNFRp55
2/2 and IFN-
cR
2/2 mice with E40-pOva as well as E40-pBla resulted in a
bacterial load of log10CFU 7.460.1 and 7.360.1, respectively and
was comparable to the bacterial load of infected WT mice
(log10CFU 7.460.1) (Figure 8A).
After infection of IFN-cR
2/2 mice no significant changes in the
splenic cell subpopulations were observed (Figure 8C) compared to
infection of WT mice. However, the percentage of all blue cells
increased significantly (IFN-cR
2/2 5.960.9% versus WT 3.161.1%)
( F i g u r e8 B ) .L i k e w i s e ,t h ep e r c e n t a g eo fb l u eG r - 1
+, F4/80
+, CD11c
+
and CD49b
+, but not CD3
+ and CD19
+, cells increased significantly
(Figure 8D). Taking both, the total number of blue cells as well as
changes in the cell composition into account, no significant alterations
in the composition of blue cells was found (Figure 8E). These data
indicate that IFN-cR deficiency leads to an increased number of cells,
in which Yops are injected, but the composition of blue cells is
comparable with that of infected C57BL/6 mice.
Infection of TNF-Rp55
2/2 mice led to a significant increase in
the percentage of Gr-1
+, F4/80
+ and CD11c
+ cells, and a
significant decrease of C19
+ cells compared with WT mice
(Figure 8C). The percentage of total blue cells was significantly
higher after infection of TNF-Rp55
2/2 (7.661.1%, p,0.001)
compared with infection of WT mice (3.161.1%) (Figure 8B). In
line with these findings, all subpopulations (F4/80, Gr-1, CD11c,
CD49b, CD19 and CD3) showed a significantly increased
percentage of blue cells in infected TNFRp55
2/2 mice
(Figure 8D). The composition of blue cells changed leading to a
significantly increased number of blue Gr-1
+ and F4/80
+ cells
compared to WT mice (Figure 8E). These data suggest that
TNFRp55 deficiency leads to a more frequent injection of Yops
into F4/80
+ and Gr-1
+ cells.
To investigate the localization of yersiniae in the spleen after
infection of mice, splenic sections were prepared and immunochem-
istry using anti-Yersinia Hsp60 antibodies was performed (Figure 8F).
HistologicalandimmunohistologicalstudiesrevealedthatYeformed
Figure 4. Distribution of Yop injection in cultured splenocytes. Splenocytes were infected with E40-pBla (MOI 50) for 1 h. Subsequently cells
were stained with CCF4-AM as well as antibodies against indicated surface markers. (A) Percentage of splenocytes expressing the indicated surface
markers. (B) Percentage of blue cells of the indicated subpopulations (C) Percentage of blue cells expressing one of the indicated surface markers.
Data are summarized as the mean6SD of three independent experiments.
doi:10.1371/journal.ppat.1000551.g004
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PLoS Pathogens | www.plospathogens.org 8 August 2009 | Volume 5 | Issue 8 | e1000551Figure 5. Detection of Yop injection in splenocytes derived from infected mice. Mice were infected with indicated Yersinia strains and
isolated splenocytes were stained with CCF4-AM. In some experiments, cells were additionally stained with antibodies specific for cell surface markers
(B–D). Subsequently cells were analyzed by flow cytometry. (A) Dot plots show cells gated on high levels of green fluorescence of the substrate CCF4
(viable cells) plotted versus the blue fluorescence revealing Yop-injection (infection dose 5610
5 for 2 days). (B) Four mice (two independent
experiments with each two animals) per group were infected with 5610
5 E40-pBla for indicated time periods or with (C) indicated numbers of
bacteria for two days and the log10 CFU in the spleen (upper panel) and the percentage of blue cells (lower panel) was determined. Data represent
the mean6SD. (D) summarizes the correlation between the log10 CFU and the percentage of blue cells in the spleen of E40-pBla infected C57BL/6
mice by using data of experiments with different infection dose as well as different time ranges of infection (n = 84). A sigmoidal regression curve
was calculated (goodness of fit r
2=0.64, sy.x = 0.5). (E) summarizes the percentage of splenocytes expressing the indicated surface markers prior to
and after infection with indicated Yersinia strains (infection dose 5610
5 for 2 days). Data represent the mean6SD of 5 uninfected, 5 E40-pOva or 22
E40-pBla infected mice of more than five independent experiments. (F) depicts the percentage of blue cells after infection with E40-pBla for each
indicated subpopulation and (G) shows the mean6SD of the percentage of blue cells expressing one of the indicated surface markers summarizing
11 independent experiments with two mice (lowest panel), n = 22. Comparison of all groups with each other by one-way ANOVA analysis and
Bonferroni correction revealed significant differences p,0.05 in: (B) for CFU and for % blue cells: as indicated by asterisks, in (C) for CFU: 5610
1 versus
5610
3 5610
4,5 610
5 or 5610
6 and 5610
2 versus 5610
3 ,5 610
4 and 5610
5, for % blue cells: 5610
1,5 610
2 or 5610
3 versus 5610
4 ,5 610
5,o r5 610
6,
5610
4 versus 5610
5. Asterisks indicate differences in (E) if uninfected versus infected is compared (One-Way ANOVA with Dunnett corrections,
p,0.05).
doi:10.1371/journal.ppat.1000551.g005
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differences in the splenic architecture or localization of yersiniae in
the spleen of WT or knockout mice were not observed.
To further address why in TNFRp55
2/2 and IFN-cR
2/2 mice
increased numbers of Yop injected spleen cells were found,
splenocytes of C57BL/6, TNFRp55
2/2 and IFN-cR
2/2 mice
were infected in vitro for one hour with different MOI of E40-pBla
and the percentage of blue cells was determined. The frequency of
blue cells for the different MOIs was not significantly different
between C57BL/6 and TNFRp55
2/2 or IFN-cR
2/2 splenocytes
(Figure S4) suggesting that splenocytes of wildtype, TNFRp55
2/2
and IFN-cR
2/2 mice upon infection with Ye display a
comparable frequency of Yop injection.
Discussion
Injection of Yop effector molecules into host cells by the TTSS
is an important strategy of Ye to suppress the host immune
response. However, detection of Yop injection in animal infection
models has been difficult so far. Several tools have been employed
to detect injection of bacterial proteins into host cells, but their
usefulness has been limited to certain in vitro models [8,25–28]. In
similar, results published by Briones et al. and own attempts to
create a Cre-recombinase based reporter system to monitor Yop
injection into host cells produced promising results in cell culture
experiments but failed to deliver a valuable tool in mouse infection
models [29]. Recently however, Marketon et al. demonstrated that
Yop-b-lactamase fusion proteins can be utilized to monitor Yop
injection in vivo [30]. In this study we applied this tool to Ye
infection and tested whether it might be useful to detect Yop
injection in vitro and in vivo.
In line with the report by Marketon et al. [30], the use of control
strains such as DYscN-pBla and E40-pOva revealed that detection
of b-lactamase reporter activity depends on injection of the
YopE53-Bla fusion protein. Therefore, internalization of bacteria
does not account for reporter activity. Yop injection into host cells
Figure 6. Determination of Yop injection in B cell populations. (A) Desferrioxamine conditioned mice were mock-infected or were infected
with 5610
5 E40-pBla for two days. Splenocytes were then stained with CD19-APC, CD21-PE-Cy7 and CD23-APC-Cy7 and with CCF-AM and then
analyzed by flow cytometry. Cells were gated for viable CD19
+ cells and then analyzed for expression of blue and green fluorescence as described in
Figure S2. All viable CD19
+ cells (total) or blue fluorescent CD19
+ cells were then analyzed for CD21 and CD23 expression. CD21
hiCD23
2 cells were
defined as MZ (marginal zone B cells), CD21
+CD23
+ as FO (follicular B cells) and CD21
2 as NFB (newly formed B cells). In each diagram 10000 events
are depicted. The percentage of each of these populations is indicated showing a representative experiment and percentages of the subpopulation
are indicated for this experiment. (B) depicts the distribution of MZ, FO and NFB of CD19
+ cells prior to and after infection of mice with E40-pBla.
Asterisks indicate significant differences compared to uninfected (p,0.05) (C) Mean and SEM of the percentage of blue cells for each CD19
+
subpopulation. (D) shows the mean and SEM of the distribution of each subpopulation of all blue fluorescent CD19
+ cells. In total four mice per
group in two independent experiments were analyzed.
doi:10.1371/journal.ppat.1000551.g006
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PLoS Pathogens | www.plospathogens.org 10 August 2009 | Volume 5 | Issue 8 | e1000551Figure 7. Changes of CD69 expression in splenocyte populations after Yersinia infection. (A) Cultured splenocytes were infected with E40-
pBla (MOI 50) or mock-infected for 1 hour or (B) desferrioxamine conditioned C57BL/6 mice were left untreated or infected with 5610
5 E40-pBla for
two days and the splenocytes were then isolated. Splenocytes were stained with anti-CD19-APC, anti-CD69-PE-Cy7 and subsequently with CCF4 and
analyzed by flow cytometry. Cells were gated (as shown in Figure S3) for high green fluorescence (viable cells) and B cells (CD19
+). Left panels show
histograms for CD69 expression of non-infected cells gated for viable CD19
+ cells (black line) or of E40-pBla infected cells gated for all viable CD19
+
cells (total, red line), gated for green
+ blue
+ CD19
+ cells (blue line) or green
+ blue
2 CD19
+ cells (green line). Mean fluorescence intensities (MFI) of
CD69 expression are depicted for this representative experiment. Right panels show the means and SEM of the x-fold increase of MFI of the indicated
cells compared to uninfected of (A) three independent experiments or (B) two independent experiments with a total of five mice per group. Asterisks
indicate significant differences, p,0.01.
doi:10.1371/journal.ppat.1000551.g007
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PLoS Pathogens | www.plospathogens.org 11 August 2009 | Volume 5 | Issue 8 | e1000551Figure 8. Impact of IFN-cR and TNF-R deficiency on Yop injection. IFN-cR
2/2, TNFRp55
2/2 and control C57BL/6 mice were infected with E40-
pBla and two days later (A) bacterial load in the spleen and (B) percentage of blue cells was determined. Each dot depicts the results for one single
mouse (in total 8–22 mice were investigated). Data in (C) show the mean and SD of the distribution of cell subpopulations expressing indicated
markers, in (D) the mean and SD of percentage of blue cells of each indicated subpopulation and in (E) the mean and SD of the percentage of the
indicated subpopulations of blue cells. Asterisks show significant differences between all groups compared (A, B, one-way ANOVA with Bonferroni
corrections, p,0.05) and differences between control mice and knockout mice (C, D, E; one-way ANOVA, with Dunnett corrections, p,0.05). F.
Immunohistology of infected spleen of indicated mice. Splenic sections were stained with anti-hsp60 and counterstained with Mayer’s hemalaun.
White arrowheads mark lymph follicle and black arrows colonies of yersiniae. All the experiments were repeated more than four times using in total
8–22 mice. Marked regions are shown at higher magnification in lower panels.
doi:10.1371/journal.ppat.1000551.g008
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C57BL/6 splenocytes in cell culture experiments. In vitro
experiments with splenic subpopulations indicated that Yop
injection occurs with similar efficacy into macrophages, dendritic
cells, granulocytes, NK cells, T cells or B cells in cell culture. We
conclude that the different immune cell subpopulations display the
same prerequisites for Yop injection. From these data it is
conceivable that Yop injection in vivo actually reflects the
interaction frequency of bacteria with distinct splenic subpopula-
tions.
The usefulness of this reporter system in cell culture experiments
could be demonstrated by investigating the importance of b1-
integrins for Yop injection. It is widely accepted that b1-integrins
play an important role for adhesion to host cells and eventually for
internalization of yersiniae via the direct or indirect interaction
with invasin and YadA, respectively [34,41–43]. In line with this,
the number of adhering Ye to fibroblasts which lack b1-integrins
was reduced by 40% compared to cells expressing b1-integrins. In
contrast, Yop injection (measured as percentage of blue fluorescent
cells) into fibroblasts which lack b1-integrins was dramatically
reduced by 95% compared to fibroblasts expressing b1-integrins.
These data are in line with a recent report [35] which suggested a
central role for b-integrins for Yop injection. Nevertheless,
detection of YopE translocation by immunoblots was still
detectable in GD25 cells which lack b1-integrins, indicating that
other surface molecules beside b1-integrins may also play a role to
modulate Yop injection. At this point it is not clear which other
surface molecules beside b1-integrins affect Yop injection and
whether depending on the cell types in which Yops are injected
different surface molecules modulate Yop injection in vitro and in
vivo.
After Y. pseudotuberculosis infection b1-integrin mediated signal
transduction leading to RhoGTPase activation seems to be the
prerequisite for initiation of Yop effector injection [35]. By using
the Rac1 inhibitor NSC23766 it was excluded that Rac1 plays a
role for Yop injection and because both TcdB (inhibitor of RhoA,
Rac1, Cdc42, RhoG, Tc10) and C3 exotoxin (RhoA, RhoB,
RhoC inhibitor) inhibited Yop injection, RhoA, RhoB and RhoC
were identified as putative candidates for this effect [35]. In
contrast, the siRNA experiments presented herein suggest that
both Rac1 and RhoA play a role for Yop injection after Ye
infection of HeLa cells. Interestingly, in the present study the Rac1
inhibitor NSC23766 also did not inhibit Yop injection. NSC23766
was demonstrated to bind to Rac1 and to prevent binding to and
activation of Rac1 by the Rac1-specific guanine nucleotide
exchange factors (GEF) Tiam1 and Trio. However, it was
described that NSC23766 seems not to prevent binding to and
activation of Rac1 by the more promiscuous GEF Vav [44,45]. As
Vav is able to activate both RhoA and Rac1, but not Cdc42
[44,45], one may speculate that Vav or other GEFs, rather than
Tiam1 and Trio, might be involved in Rac1 mediated Yop
injection. One has to anticipate that NSC23766 inhibits Yersinia
triggered Rac1 activation only partially and in a GEF specific
manner which has to be proven in future studies. In addition it will
be interesting to find out which specific GEFs are involved in
facilitating Yop injection. Taken together this study clearly
pinpoints that b1-integrins play a role in facilitating Yop injection.
The YopE-Bla reporter system turned out to work highly
efficiently when expressed in E40 (O9) strain, but not in WA-314
(O8) strain; thus, 80% of in vitro infected splenocytes displayed
blue fluorescence upon infection with E40-pBla strain, but only
26% upon infection with WA-pBla strain (data not shown).
Moreover, in C57BL/6 mice infected with E40-pBla 3% of
splenocytes displayed blue fluorescence, while in WA-pBla infected
mice we could hardly detect any blue cells for yet unknown
reasons. We therefore used the E40 strain for all experiments
included in this study. The low virulence of serotype O9 strains
such as E40 strain or O3 strains in mice is at least partially caused
by their disability to synthesize the iron chelating siderophore
yersiniabactin due to their lack of the HPI island [46,47]. This
could be ‘‘complemented’’ by treatment of mice with desferriox-
amine which allows to study Ye O9 and Ye O3 infection in mice
[48–50]. The disadvantage of desferrioxamine, however, is that it
might have immunosuppressive effects on phagocytes [51,52].
Infection of desferrioxamine-conditioned C57BL/6 mice re-
vealed a correlation between the percentage of blue cells and the
bacterial burden in the spleen which can be best described by a
sigmoidal dose response curve. Taking the background staining of
0.260.2% into account, a detection limit of 0.6% blue cells was
estimated using the sigmoidal regression curve. To reach 0.6%
blue cells in the spleen the bacterial burden would have to be at
least 4610
5 bacteria representing a MOI of 0.01. The cell culture
experiments, however, showed that much higher MOI are
required to achieve half-maximal numbers of blue spleen cells.
Therefore, higher efficacy of YopE-bla detection might be due to
abscess formation with Ye microcolonies which may allow more
Ye bacteria to interact with single host cells at abscesses.
Alternatively the TTSS machinery might be upregulated during
infection in spleen compared to cell culture. Most experiments
were carried out at conditions with a bacterial burden of 5610
7
bacteria in the spleen resulting in 3.161.1% of blue, Yop-injected
cells.
Determination of the percentage of blue cells in each
subpopulation revealed that Yop injection occurred into Gr1
+
(predominantly granulocytes), CD11c
+ (predominantly dendritic
cells), F4/80
+ (predominantly macrophages) and CD49b
+ cells
(predominantly NK cells). In contrast, only in a small percentage
of the CD3
+ (T cells) and CD19
+ (B cells) cells, Yop injection was
detectable. However, due to the high total number of B cells
(.50% of spleen cells) their contribution to the total number of
blue cells is about 40%. Further characterization of B cells
revealed that the composition of B cell subpopulations changed
after infection leading to an increased number of CD19
+CD21
lo
(NFB) while the number of CD19
+CD23
+CD21
+ cells (FO) did not
change and the number of CD19
+CD21
hi CD23
2 (MZ) slightly
decreased. Thus, after infection NFB appear to either proliferate
in or immigrate into the spleen.
Yop injection was predominantly detectable in follicular B cells
and to a lesser extent in NFB.
Naı ¨ve follicular B cells reside in the ‘‘follicular niche’’ and may
present T-dependent antigens to activated T cells. The follicular
niche therefore represents the major site at which recirculating B
cells mediate T-dependent immune responses to protein antigens
[53]. Interestingly, in contrast to the Ye infection model presented
here, injection of the Bla-reporter into B cells was not described in
Y. pestis infection [30]. It remains unclear whether these
discrepancies are due to different Yersinia species, different mouse
strains or differences in the reporter systems. Nevertheless, it is
striking that after Y. pestis infection the analysis gate which was
used to define the viable cells was rather small indicating that most
spleen cells were necrotic or apoptotic under the chosen
experimental conditions. It might well be that Yop-injected B
cells might have been missed by the analysis due to high cell death
rates in Y. pestis infection.
In Ye infection, however, interaction of B cells with Ye is
prominent. This finding is in line with the analysis of histological
sections of the spleen. Thus, E40-pBla microcolonies were
observed adjacent to lymphoid follicles (B cell zones). Balada-
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a tropism to B and T cell zones in lymph nodes. In our studies we
found yersiniae always adjacent to lymph follicles in the spleen and
the most frequent interaction of yersiniae with host cells was that
with B cells, specifically with CD19
+CD21
+CD23
+ B cells which
are defined as follicular B cells (FO). FO B cells organize into the
primary follicles of B cell zones focused around follicular dendritic
cells in the white pulp of the spleen. Thus in our system Ye appear
to preferentially colonize in the follicular niche and interact
frequently with follicular B cells. Whether Ye are actively
migrating to this region or may be trapped by e.g. dendritic cells
needs to be further investigated. Infection with Ye was associated
with increased CD21 and CD23 expression levels of FO B cells
which suggests that B cells may be activated after interaction with
yersiniae. Specific activation of Yop injected B cells was also
supported by the observation that the early B cell activation
marker CD69 was upregulated in blue B cells. From this data we
can conclude that Yop-injected B cells were specifically activated
by Ye despite injection of Yops. Whether Yop-injected B cells may
undergo subsequent cell death or are affected in their ability to
produce IgM or to undergo differentiation needs to be investigated
in future study.
Previous studies revealed that TNF-a and IFN-c are important
for defense against Ye infection [36–38,40]. Therefore, we were
interested whether these cytokines may affect Yop injection. The
experimental conditions were chosen in a way that the bacterial
burden in the spleen of the various mouse strains was comparable.
Infection of IFN-cR- and TNFRp55-deficient mice revealed a
higher number of blue cells in the spleen compared to infected
WT mice indicating that either more host cells interacted with
yersiniae or the threshold which allows detection of Yop injection
was lower in knock-out mice. Histological analysis of the Ye
microcolonies in WT and knockout mice revealed comparable
tissue distribution of Ye and comparable tissue alterations by the
infection. In vitro infection of splenocytes from IFN-cR- and
TNFRp55 deficient and wildtype mice did not reveal significant
differences in terms of Yop injection. Therefore it remains widely
unclear why more blue cells are found in IFN-cR- or TNFRp55
2/
2 mice compared to wild type mice. However, we cannot exclude
that minor changes in spleen cell subpopulations may partially
cause the different numbers in knock-out and wild type mice.
In further experiments we tried to detect Yop injection into cells
of the PP after orogastric infection. However, we were not able to
detect blue PP cells under these conditions (data not shown). One
explanation might be that the number of bacteria that establish
infection in the PPs is lower than that in spleen [55]. Thus, one
may speculate that the number of bacteria attached to a single host
cell in PP might be lower than that in spleen which might result in
Yop injection below the detection limit of this reporter system.
Alternatively or in addition, the number of cells in which Yops
were translocated might be too low.
The Bla reporter system described herein is so far the only
reporter system that allows tracking of Yop injection in Ye infection
invivoona single celllevel ina mouseinfection model.Nevertheless,
the system needs to be improved in order to accomplish a more
sensitive reporter system. The disadvantages of CCF-4 as a substrate
for b-lactamase is that the amount of Yops translocated cannot be
quantified and that CCF-4 displays limited sensitivity. Moreover,
CCF-4 does not allow studying Yop injection in histological sections
in situ. Current experiments in our laboratory aim at overcoming
these limitations with new compounds.
Taken together, the Ye Bla reporter system can be successfully
used in cell culture and in mouse infection models for detection of
Yop injection on a single cell level, and thus could be a valuable
tool for quantitatively screening for genetic factors involved in Yop
secretion and injection at the bacterial as well as at the host cell
side, or to identify drugs which target Yop secretion or injection,
respectively.
Materials and Methods
Bacterial strains and growth conditions
Y. enterocolitica E40 strains used in this study are listed in table 1.
All bacterial strains were grown overnight in Luria-Bertani (LB)
broth at 27uC supplemented with 50 mg/ml meso-diaminopimelic
acid, 50 mg/ml nalidixic acid, 50 mg/ml kanamycin, and 400 mM
Na-arsenite (all from Sigma Chemical, St. Louis, MO) in
combinations according to the indicated resistances and supple-
mentation needs (table 1). A 1:25 dilution of the bacterial culture
was incubated for additional 3 h at 37uC. The bacteria were
washed once with phosphate-buffered saline (PBS; Invitrogen,
Karlsruhe, Germany) and the optical density at 600 nm was
determined.
Plasmid constructions
All plasmid constructs and bacteria used are listed in table 1. To
generate pMK-Bla, as a starting vector pBME53-yopT [56], a
pACYC184 derivate containing a HindIII-sycE-yopE/sycE promot-
er-yopE gene fragment encoding the first 53 N-terminal amino
acids (aa) -BamHI-YopT -SalI construct was used. YopT was
replaced by a translational fusion of the coding sequences (CDS) of
the SV40 nuclear localization signal (nls) and the CDS of Cre
recombinase resulting in pBME53-Cre. This vector was digested
with HindIII and SalI and the resulting sycE-yopE53-cre fragment
was inserted into pIV2 [57]. pIV2 was derived from a small cryptic
plasmid of an apathogenic Y. enterocolitica strain (kindly provided by
Eckhard Strauch, Federal Institute for Risk Assessment, Berlin)
resulting in pIV2-SycE-YopE53-Cre. To create a balanced system
that compels stable retention of the reporter vector in Y.
enterocolitica during in vivo infections, the Y. enterocolitica asd gene
coding for the L-aspartate-dehydrogenase, an enzyme that is
required for the synthesis of the cell wall component L-lysine via
the meso-2,6-diaminopimelic acid (DAP) pathway and therefore
essential for bacterial growth and replication was inserted into the
pIV2-SycE-YopE53-Cre plasmid as follows: The asd gene and its
59region were amplified from Y. enterocolitica E40 chromosome by
using the oligonucleotides 59- AGC TTT AGG GCC CAA AAA
CAG CAA CAC CGT TGC C-39 and 59-AAC TCG AGT TAC
AGA AAA TTC GCA GC-39. The PCR product was then
digested with ApaI and XhoI and inserted into those sites of pIV2-
SycE-YopE53-Cre, thus yielding pMK4. Together with the
deletion of the asd gene from its chromosomal locus (see below)
in the utilized bacteria, this grants stable retention of the reporter
plasmid, by complementing the otherwise lethal DAP auxotrophy
of the Y. enterocolitica E40 Dasd strain.
The b-lactamase (bla) gene was amplified from pCR2.1 (Invitro-
gen, Karlsruhe, Germany) using the primers 59-GGA TCC ATG
AGT ATT CAA CAT TTC CG-39 and 59-GTC GAC AAC
TTG GTC TGA CAG TTA CC-39. The PCR product was
subcloned into pCR-Blunt II and subsequently donated as a
BamHI / SalI fragment to pBME53-YopT, thus replacing the
sequence coding for YopT and fusing the translation product to
the YopE53 domain, yielding the plasmid pBME53-Bla. pBME53-
Bla was digested with HindIII-SalI and the resulting HindIII-sycE-
yopE53-bla-SalI fragment replaced the HindIII-sycE-yopE53-cre-SalI
fragment of pMK4 yielding pMK-Bla.
To generate a control vector, the sequence coding for b-lactamase
was excised by BamHI / SalI digestion from pBME53-bla and
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[58] encoding an internal ovalbumin fragment comprising aa 247–
355, yielding pBME53-ova. From this plasmid, a fragment
encoding the YopE53-Ova247–355 fusion protein was yielded by
HindIII / SalI digest and used to replace the HindIII / SalI fragment
encoding YopE53-Bla in pMK-Bla yielding pMK-Ova.
Generation of Y. enterocolitica strains - Y. enterocolitica E40 is a clinical
isolate that belongs to the serotype O:9 [27]. To generate Y.
enterocolitica E40 Dasd the asd gene in this strain was disrupted by
allelic exchange. The pMK3 asd mutator plasmid was constructed
as follows: (i) the 59end of the asd gene was amplified from Y.
enterocolitica E40 by using the oligonucleotides 59-GAT CGT CGA
CAT GGT CGG CTC AGT A-39and 59- CAG TGA ATT CCG
GCG TCC AAT CCA ATA-39 and the 39end by using the
oligonucleotides 59-GAT CTC TAG ATT CGC AGC ATA CGG
C-39and 59-GAC TGA ATT CGT GAC TGC GGC CAC T-39.
The PCR product corresponding to the 59 end of asd was digested
with SalI-EcoRI and that corresponding to the 39 end with EcoRI-
XbaI. The restricted PCR products were then ligated into
pBluescript II SK (+) (Stratagene, Cedar Creek, USA) digested
with SalI-XbaI, which originated pMK1 that contains a deleted asd
gene (Dasd). The Dasd allele was subcloned as a SalI-XbaI DNA
fragment into pMRS101 [59] digested with the same enzymes,
yielding pMK2. The asd mutator plasmid pMK3 was obtained
after digestion of pMK2 with NotI and religation of the vector.
The strains E40-pBla and E40-pOva have been generated by
electroporation of pMK-Bla or pMK-Ova, respectively into Y.
enterocolitica E40 Dasd. Thus, the DAP auxotrophy of these strains
was supplemented, thereby creating a metabolically balanced
system assuring stable plasmid retention.
To enable the generation of reporter strains with pYV40
virulence plasmids that had been subjected to mutagenesis
previously, pYV40 was cured from Y. enterocolitica E40-pBla as
described previously [60]. Screening for arsenite susceptible clones
yielded Y. enterocolitica E40 Dasd pYV
2 pMK-Bla (pYV
2 Dasd pBla).
Y. enterocolitica E40 Dasd yscND169–177 (DYscN-pBla) was
created by electroporation of pMSL41 [27,61] into pYV
2 Dasd
pBla. The plasmid pMSL41 has been yielded by deletion of
yscN169–177 from pYV40.
Analyses of Yop secretion
Secretion of the YopE53-b-lactamase fusion protein was
examined by the preparation of released proteins as described
previously [62]. Overnight cultures grown at 27uC were diluted
1:20 into brain heart infusion broth (Difco, Heidelberg, Germany).
After 2 h of incubation at 37uC, Yop secretion was induced by the
addition of 5 mM EGTA for Ca
2+ sequestration, 15 mM MgCl2
and 0.2% glucose. 3 h after induction secreted proteins were
precipitated from the culture supernatant with trichloroacetic acid.
Protein concentration was determined by Bradford assay (Bio-
Rad, Hercules, USA) and 15 mg of protein was loaded on a 12%
SDS-PAGE. Separated proteins were transferred electrophoreti-
cally to an Immobilon-P PVDF membrane (Millipore, Bedford,
USA). For immunostaining, polyclonal rabbit anti-YopE was used.
Immunoreactive bands were visualized by incubation with
peroxidase-conjugated swine anti-rabbit IgG antibody (1:1000)
(DAKO, Glostrup, Denmark) using enhanced chemiluminescence
reagents (ECL, Amersham Biosciences, Freiburg, Germany) and
CL-XPosure Film (Thermo, Rockford, IL).
Cell culture and in vitro infections
The fibroblast-like GD25 and GD25-ß1A cell lines were a kind
gift from R. Fa ¨ssler (Max-Planck-Institute for Biochemistry,
Martinsried, Germany). The murine GD25 cells were derived
from the embryonic stem cell clone G201 which is deficient in the
ß1-integrin subunit [63]. The stably transformed cell line GD25-
ß1A was obtained by electroporation of wild-type integrin ß1A
cDNA into GD25 cells [64]. GD25 cells not expressing ß1-
integins were cultivated in DMEM (Gibco) supplemented with
10% FCS , the GD25-ß1A line expressing ß1-integrins was
maintained in DMEM supplemented with 10% FCS and 10 mg/
ml puromycin.
HeLa cervical epithelial cells (ATCC CCL-2.1) were grown in
RPMI 1640 (Biochrom KG, Berlin, Germany) supplemented with
10% fetal bovine serum (Sigma Chemical), 2 mM L-glutamine
(Biochrom KG), penicillin (100 U/ml), and streptomycin (100 mg/
ml) (Biochrom KG) in a humidified 5% CO2 atmosphere at 37uC.
Suspensions of single spleen cells were prepared from naı ¨ve
C57BL/6 mice as described below. For infection with a MOI of
100 for microscopic observation and Western Blot analysis or with
a MOI of 50 or as indicated for FACS analysis bacteria were spun
onto the cells (5 minutes, 400 g). After 1 h incubation at 37uC,
gentamicin (100 mg/ml) was added to terminate infection. To
assess the impact of inhibitors of RhoGTPases on Yop injection,
cells were treated with 200 ng/ml medium Clostridium difficile toxin
B 10463 (TcdB; kind gift I. Just, Institute for Toxicology,
Hannover Medical School, Hannover, Germany) 2 h prior to
infection or 100 mM Rac1 inhibitor (NSC23766; Calbiochem, San
Diego, CA) 3 h prior to infection.
Western Blot analysis of Yop injection
To analyze Yop injection by immunoblotting, cells were grown
in 94 mm dishes, and then were left untreated uninfected or were
infected with the E40-pBla reporter strain or the DYscN-pBla
strain (MOI 50) as a control for 90 minutes. Cells were lysed in
200 ml PBS with 1% Triton-X (Sigma). 100 mg cell lysate protein
was analyzed by SDS-PAGE and immunoblotting was performed
in similar as already described for detection of Yop secretion with
the exception that HRP Substrate Plus (P. J. K., Kleinbittersdorf,
Germany) was used instead of ECL and in some cases film
exposure was extended to 30 min for increased sensitivity.
Adhesion to cultured cells
To assay adhesion of the E40-pBla reporter strain to HeLa,
GD25 and GD25-ß1A cells, the respective cells were seeded on
coverslips in a 24-well plate (Nunc Life Technologies, Wiesbaden,
Germany). One hour after infection (MOI 50), cells were washed
with PBS, fixed with 4% PFA and stained with fuchsine. All
samples were prepared in duplicates, of which cells and bacteria
were counted in 6 representative details.
RNA interference
For the knock-down of RhoGTPases, the predesigned and
prevalidated siRNA oligonucleotides Hs RhoA-6, Hs Rac1-6 and
Hs Cdc42-7 were purchased from Qiagen (Hilden, Germany).
AllStars negative control siRNA (Qiagen) was used as a
nonsilencing control. 3610
4 HeLa cells were transfected with
siRNA (5 nM) in a 12-well plate 48 h prior to infection using
HiPerFect transfection reagent (Qiagen) according to the manu-
facturer’s fast forward protocol.
Successful knock-down was confirmed on RNA level by qPCR.
Total mRNA of infected HeLa cells was extracted using RNeasy
Mini Kit (Qiagen). 1 mg of total mRNA was reverse transcribed to
cDNA using QuantiTect Reverse Transcription Kit (Qiagen).
Real-time qPCR was performed on a LightCycler 480 (Roche
Diagnostics, Mannheim, Germany) using QuantiTect SYBR
Green PCR Kit and the respective QuantiTect Primer Assays
(Rac1 1, RhoA 1, CDC42 2 and GAPDH 2). Relative expression
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levels of the target genes were normalized to glyceraldehyde-3-
phosphate dehydrogenase RNA expression. Thus, we could demon-
strate at least 75% knock-down by the used siRNAs at mRNA
expression level (data not shown).
In vivo infections
C57BL/6 mice were purchased from Harlan Winkelmann
(Borchen, Germany), TNF-Rp55
2/2 [66] and IFN-cR
2/2 [67]
mice with a genetic C57BL/6 background were bred under
specific pathogen-free conditions. Animal experiments were
performed according to german law with permission of the
Regierungspra ¨sidium Tu ¨bingen. The experiments were performed
with 6–8-week old female mice. To enable profound infection,
2.5 mg desferrioxamine (Sigma Chemical) in 200 ml PBS were
administered to the mice intravenously one hour before infection.
Mice were infected with 5610
5 bacteria from frozen stock
suspensions in 200 ml PBS iv. into the tail vein. Uninfected
control mice were in parallel treated with desferrioxamine. After
two days, mice were sacrificed by CO2 asphyxiation and their
spleens were surgically removed and placed in ice-cold HBSS
(Ca
2+ and Mg
2+ free Hanks’ balanced salt solution) (Biochrom)
supplemented with 2% v/v fetal calf serum (FCS) (Sigma
Chemical) and 10 mM HEPES buffer (Biochrom). Single cells
were obtained by forcing the organs with a 5 ml syringe pestle
through a 40 mm-pore nylon mesh cell strainer (Falcon; BD
Labware, Franklin Lakes, USA). Cell suspensions were washed
twice with ice-cold HBSS. Red blood cells were lysed from spleen
samples by incubating the cell suspensions for 5 min at room
temperature in lysis buffer (170 mM Tris, 160 mM NH4Cl,
pH 7.4) followed by two washes in ice-cold HBSS.
Detection of Bla-activity by microscopy
For the detection of Bla activity by immunofluorescence
microscopy, HeLa cells were washed once with PBS and covered
with 16CCF4-AM staining solution supplemented with proben-
ecid, prepared according to the manufacturer’s instructions. Cells
were incubated 30 min at a dark place at room temperature prior
to observation with an Axiovert 200 microscope. Pictures were
taken with an Axiocam HRc and Axiovision 4.4 Software was
used to capture the shots and to produce overlay images (Carl
Zeiss Microimaging, Esslingen, Germany). Filter sets for individual
observation of coumarin and fluorescein fluorescence respectively
were purchased from AHF (Tuebingen, Germany).
Detection of Bla activity by flow cytometry
For the detection of Bla activity by flow cytometry, cells were
resuspended in 16CCF4-AM staining solution supplemented with
probenecid, prepared according to the manufacturer’s instructions
(Invitrogen, Carlsbad, CA) and incubated 30 min at a dark place
at room temperature prior to FACS analysis.
In case the detection of Bla activity was combined with the
staining of leukocyte surface markers, 10
6 cells per staining were
resuspended in PBS. To avoid non-specific labeling, FccII/III
receptors were blocked by preincubation with mAb 2.4G2 for
20 min at RT.
Flow cytometry analysis was performed on a Dako Cyan
cytometer using Summit 4.3 software (Dako, Carpinteria, CA) or
on a BD Biosciences (Heidelberg, Germany) FACSCanto II using
FACSDiva software. From each sample, at least 100,000 cells have
been analyzed; error bars indicate the standard deviation between
samples from different animals. An exemplary description of the
steps how analysis was performed is shown in Figure S1.
Immunohistology
For immunohistological analysis the tissues were embedded in
Tissue-Tek OCT compound (Nunc, Roskilde, Denmark), snap-
frozen in liquid nitrogen, and stored at 280uC. Frozen sections
were prepared and stained by an immunoperoxidase method using
3,3-diaminobenzidine-tetrahydrochloride acid (DAB; Sigma, Dei-
senhofen, Germany) as chromogenic substrate. Nonspecific
binding sites were blocked by incubation of the sections with
PBS containing 10% fetal calf and 5% normal goat serum. For the
yersiniae staining, rabbit anti-Hsp60 antibody was diluted 1:200 in
PBS containing 5% FCS and 5% normal goat serum for 1 h at
room temperature. The secondary antibody was peroxidase-
conjugated affinity purified F(ab’)2 fragment goat anti rabbit IgG
(Jackson ImmunoResearch; diluted 1:200). Isotype-matched
irrelevant rabbit IgG was used in controls and revealed no
staining signal. The sections were counterstained with Mayer’s
hemalaun, mounted, and assessed microscopically on a BX51
microscope (Olympus Optical Co, Leinfelden, Germany) by two
independent investigators. Pictures were taken with a DP71
camera and analysed with cell
B software (Olympus). Immuno-
staining of controls was negative for all groups tested.
Statistics
If not otherwise stated, the means and standard deviations (SD)
of data derived by cell culture experiments are calculated from
four independent experiments. The number of mice which were
used to calculate means and SD in mouse infection experiments is
indicated in the manuscript or figure legends. Statistical analyses
were performed using one-way ANOVA analyses with either
Dunnett (comparison of control group with other groups) or
Bonferroni corrections (comparison of all groups) as indicated in
the figure legends or the text by using Graph Pad Prism software
(GraphPad Software, La Jolla, USA). This software was also used
to fit non-linear regression models.
Supporting Information
Figure S1 Example for the flow cytometry analysis after in vivo
infection. An example of the analyses for the determination of blue
cells in splenocytes after E40-pOva and E40-pBla infection of mice
is shown. (A) Forward and side scatter was analyzed of all dots
measured. (B) High green fluorescence (green) characterizes
uptake of CCF4 and therefore viability of cells, (C) shows as
green dots that the green fluorescent viable cells are mostly found
in R2. Gating with R1 and R2 results in the cell populations
shown in D. (D) Cells in gate R3 were defined as blue cells.
Found at: doi:10.1371/journal.ppat.1000551.s001 (0.30 MB
TIF)
Figure S2 Analysis of B cell subpopulations after in infection in
vitro. Splenocytes were cultured and infected for one hour with or
without E40-pBla (MOI 50). Cells were harvested and stained with
anti-CD19-APC, anti-CD21-PE-Cy7 and anti-CD23-APC-Cy7
and then incubated with CCF4. Cells were analyzed by flow
cytometry. Analysis was performed as followed. (A) Viable B cells
were defined by gating using R1 & R2 & R3. All viable CD19
+
cells (total) or blue CD19
+ cells (R4) were analyzed for CD21 and
CD23 expression. Percentages of CD212 (NFB, newly formed B
cells), CD21
+CD23
2 (MZ, marginal zone B cells) and
CD21
+CD23
+ (FO, follicular B cells) are indicated by numbers
for this experiment. In total two experiments with similar results
were performed. Mean and SEM of (B) the percentages of CD19
+
cells, (C) the percentages of blue cells of the indicated B cell
populations and (D) the percentages of the composition of total
CD19
+ blue cells are shown.
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Figure S3 Analysis of activation of B cells in cell culture.
Splenocytes were cultured and infected for one hour with or
without E40-pBla. Cells were harvested and stained with anti-
CD19-APC, anti-CD69-PE-Cy7 and MHC-II-APC-Cy7 and then
incubated with CCF4. Cells were analyzed by flow cytometry.
Analysis was performed in the following manner: (A) viable B cells
were defined by gating using R1 & R2 & R3. (B) B cells were then
further analysed for CD69 expression levels of all cells using
additionally gate R5 (green+ blue+ cells), R6 (green+ blue2 cells)
or R7 (total). Histograms for CD69 expression of uninfected or
E40-pBla infected cells are shown. Numbers indicate mean
fluorescence intensities (MFI) for one representative experiment.
Found at: doi:10.1371/journal.ppat.1000551.s003 (0.33 MB TIF)
Figure S4 Infection of splenocytes of TNFR
2/2, IFN-cR
2/2
and C57BL/6 mice in cell culture. Splenocytes were infected with
indicated MOI for one hour and subsequently cells were stained
with CCF4-AM and analyzed by flow cytometry. Data summarize
three independent experiments.
Found at: doi:10.1371/journal.ppat.1000551.s004 (0.07 MB
TIF)
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